Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Y Reginster

Showing results (1-10 of 491) with videos related to

Pageof 50
Sort By:
Clinical and Experimental Rheumatology|May 1, 2001
Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal womenJ Y Reginster
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|October 31, 2002
[Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone]J Y Reginster
Current Pharmaceutical Design|August 13, 2002
Strontium ranelate in osteoporosisJ-Y Reginster
MMW Fortschritte Der Medizin|May 9, 2001
[Status of osteoporosis therapy. A medical scandal]J Y Reginster
Revue Du Rhumatisme (English Ed.)|July 1, 1996
New bisphosphonates for the treatment of osteoporosis: concerns and hopesJ Y Reginster
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1996
[Evaluation of the preventive role of estro-progestogens and non-hormonal therapies in postmenopausal osteoporosis]J Y Reginster
Journal of Internal Medicine|May 19, 2004
Prevention of postmenopausal osteoporosis with pharmacological therapy: practice and possibilitiesJ-Y Reginster
Revue Medicale De Liege|May 1, 1994
[Calcitonin in the treatment and prevention of osteoporosis]J Y Reginster
Current Pharmaceutical Design|November 25, 2005
Oral and intravenous ibandronate in the management of postmenopausal osteoporosis: a comprehensive reviewJ-Y Reginster
Lancet (London, England)|April 25, 1992
Calcitonin and bone diseasesJ Y Reginster
Pageof 50

Showing results (1-10 of 491) with videos related to

Sort By:
Pageof 50
Clinical and Experimental Rheumatology|May 1, 2001
Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal womenJ Y Reginster
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|October 31, 2002
[Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone]J Y Reginster
Current Pharmaceutical Design|August 13, 2002
Strontium ranelate in osteoporosisJ-Y Reginster
MMW Fortschritte Der Medizin|May 9, 2001
[Status of osteoporosis therapy. A medical scandal]J Y Reginster
Revue Du Rhumatisme (English Ed.)|July 1, 1996
New bisphosphonates for the treatment of osteoporosis: concerns and hopesJ Y Reginster
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1996
[Evaluation of the preventive role of estro-progestogens and non-hormonal therapies in postmenopausal osteoporosis]J Y Reginster
Journal of Internal Medicine|May 19, 2004
Prevention of postmenopausal osteoporosis with pharmacological therapy: practice and possibilitiesJ-Y Reginster
Revue Medicale De Liege|May 1, 1994
[Calcitonin in the treatment and prevention of osteoporosis]J Y Reginster
Current Pharmaceutical Design|November 25, 2005
Oral and intravenous ibandronate in the management of postmenopausal osteoporosis: a comprehensive reviewJ-Y Reginster
Lancet (London, England)|April 25, 1992
Calcitonin and bone diseasesJ Y Reginster
Pageof 50